Literature DB >> 10628799

Immunolocalisation studies of matrix metalloproteinases-1, -2 and -3 in human melanoma.

R A Walker1, D E Woolley.   

Abstract

The matrix metalloproteinases (MMPs) are considered to have an important role in connective tissue degradation and have been implicated in the mechanisms of tumour invasion and metastatic spread. We have used immunohistochemistry to examine and compare the tissue distributions of collagenase-1 (MMP-1), gelatinase A (MMP-2) and stromelysin-1 (MMP-3) in 18 specimens of malignant melanoma, viz. 10 superficial spreading and 8 nodular melanomas. MMPs-1, -2 and -3 were demonstrated within melanoma and host tissue cells, especially at the periphery of some tumours, but were usually restricted to less than 10% of total melanoma cells. The MMPs were absent from 'normal' skin tissue distant from the tumour. MMP-2 was localised to discrete groups of cells and was especially evident at the epidermal:tumour interface, whereas MMP-3 was mainly confined to the deeper margins of melanoma. No regular pattern of MMP expression was observed for either the superficial spreading or the nodular melanomas. The variable distributions of the MMPs suggested that enzyme expression was subject to local microenvironmental regulation, possibly in response to matrix components and the cellular heterogeneity observed at the tumour margins. These in situ observations add weight to the concept that specific MMPs contribute to the mechanisms of tumour invasion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628799     DOI: 10.1007/s004280050443

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  11 in total

1.  SOX2 contributes to melanoma cell invasion.

Authors:  Sasha D Girouard; Alvaro C Laga; Martin C Mihm; Richard A Scolyer; John F Thompson; Qian Zhan; Hans R Widlund; Chung-Wei Lee; George F Murphy
Journal:  Lab Invest       Date:  2011-12-19       Impact factor: 5.662

2.  Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.

Authors:  Mingmei Liao; Ping Tong; Jinfeng Zhao; Yangde Zhang; Zhehai Li; Jiwei Wang; Xueping Feng; Man Hu; Yifeng Pan
Journal:  Pathol Oncol Res       Date:  2011-09-10       Impact factor: 3.201

3.  Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Rian Disci; Sidika Kurul; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma.

Authors:  Faruk Tas; Derya Duranyildiz; Hilal Oguz; Hakan Camlica; Vildan Yasasever; Erkan Topuz
Journal:  Med Oncol       Date:  2008-03-25       Impact factor: 3.064

5.  Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase.

Authors:  J Devy; L Duca; B Cantarelli; D Joseph-Pietras; A Scandolera; A Rusciani; L Parent; J Thevenard; S Brassart Pasco; M Tarpin; L Martiny; L Debelle
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

6.  Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression.

Authors:  Yuan-Guo Wang; Seok-Jun Kim; Jung-Hwan Baek; Hyun-Woo Lee; Seo-Young Jeong; Kyung-Hee Chun
Journal:  Exp Mol Med       Date:  2012-06-30       Impact factor: 8.718

7.  Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma - a preliminary study.

Authors:  Tatyana Vlaykova; Mateusz Kurzawski; Tanya Tacheva; Dimo Dimov; Maya Gulubova; Yovcho Yovchev; Stoyan Chakarov; Marek Drozdzik
Journal:  Biotechnol Biotechnol Equip       Date:  2014-11-13       Impact factor: 1.632

8.  BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity.

Authors:  C A Whipple; C E Brinckerhoff
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

9.  The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.

Authors:  Molly H Jenkins; Walburga Croteau; David W Mullins; Constance E Brinckerhoff
Journal:  Matrix Biol       Date:  2015-05-16       Impact factor: 11.583

10.  Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?

Authors:  Manal M Zyada; Ali A Shamaa
Journal:  Diagn Pathol       Date:  2008-06-13       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.